Spero Therapeutics Inc SPRO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/02/24 EDT
1.61UNCH (UNCH)
Volume
433
Close
1.61UNCH (UNCH)
Volume
294,110
52 week range
0.99 - 2.00
Loading...
  • Open1.53
  • Day High1.67
  • Day Low1.53
  • Prev Close1.54
  • 52 Week High2.00
  • 52 Week High Date05/08/23
  • 52 Week Low0.99
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap86.768M
  • Shares Out53.89M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change9.52

KEY STATS

  • Open1.53
  • Day High1.67
  • Day Low1.53
  • Prev Close1.54
  • 52 Week High2.00
  • 52 Week High Date05/08/23
  • 52 Week Low0.99
  • 52 Week Low Date10/26/23
  • Market Cap86.768M
  • Shares Out53.89M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change9.52

RATIOS/PROFITABILITY

  • EPS (TTM)0.41
  • P/E (TTM)3.95
  • Fwd P/E (NTM)-1.69
  • EBITDA (TTM)27.187M
  • ROE (TTM)24.95%
  • Revenue (TTM)103.78M
  • Gross Margin (TTM)-
  • Net Margin (TTM)21.98%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spero Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with unmet need. Its lead product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease, a rare orphan disease. Its partnership-directed programs consist of tebipenem HBr...
Ankit Mahadevia M.D.
Chairman of the Board
Satyavrat Shukla
President, Chief Executive Officer, Director
Timothy Keutzer
Chief Operating Officer
Esther Rajavelu
Chief Financial Officer and Chief Business Officer
Address
675 Massachusetts Ave Ste 14
Cambridge, MA
02139-3309
United States

Top Peers

SYMBOLLASTCHG%CHG
ENZ
Enzo Biochem Inc
1.05UNCHUNCH
CTMX
CytomX Therapeutics Inc
4.50UNCHUNCH
HBIO
Harvard Bioscience Inc
3.82UNCHUNCH
FBIO
Fortress Biotech Inc
1.80UNCHUNCH
PSNL
Personalis Inc
1.60UNCHUNCH